Authors
Latest:
Flip the ScriptLife sciences transformations rarely fail because of what was in the plan. They fail because of what was not. Explore five trends that will determine their success in coming years.
Latest:
The Challenges of Worker Qualification Management in PharmaLife sciences companies uniquely tasked with meeting continuous and complex compliance-reporting requirements.
Latest:
A Generational Opportunity for Talent Pipeline DevelopmentCOVID-19 creates a unique chance to refocus STEM strategies.
Latest:
How to Connect with HCPs More EffectivelyRegardless of engagement mode pursued, personalization is the key.
Latest:
Recruitment Lessons from the COVID-19 PandemicFiona Huzarski outlines four key recruitment lessons that pharma can take from the coronavirus crisis and use to move forward and thrive.
Latest:
Crisis Communication Plans in PharmaThe pharmaceutical industry must have crisis communications prepared now to anticipate unforeseen events—especially those that impact public trust.
Latest:
Clues on Equity Engagement LevelsA survey of 18 biopharmas, measuring their scope and implementation across key health equity dimensions and activities, uncovers useful context as companies seek better alignment of these goals with overall strategy.
Latest:
Restoring Hope in Mental Illness Is a Collective MissionThe importance of equitable approaches to diagnosis and treatment.
Latest:
The Promise and Peril of AI in the Physical WorldThe use of artificial intelligence (AI) in drug development has been hampered by issues that have caused a gap between AI’s potential and its full utilization in this space.
Latest:
Action Through Engagement: Alleviating COVID Concerns in Patients with Underlying ConditionsIt’s important that care for people with pre-existing conditions or at risk from serious diseases does not fall by the wayside.
Latest:
Better Supply Chains Can Better Tackle Threats to Public HealthTo effectively combat the looming threat of antimicrobial resistance, we must prioritize working together to strengthen and more responsibly manage global supply chains.
Latest:
From Concept to Commercialization: Pushing the EnvelopeDisruptive strategies are essential to grow the pharma industry.
Latest:
Environmental Sustainability in the Life Sciences Sector: Embedding ChangeFor many years, high energy use and its impact on the environment by businesses within the life sciences sector had been generally overlooked in national and global efforts to combat climate change. But with “carbon neutrality” the new buzzwords, how is the sector embracing this push for change?
Latest:
Powering Pipelines Forward: Approach Science DifferentlyWhy tapping the value generated for the next set of therapies is critical.
Latest:
Out-licensing Deals Between Chinese Pharma and Global Companies are Heating UpA growing number of domestic drug developers are setting their sights on overseas markets.
Latest:
Paving the Path to IPO: How to Build Compliant Financial Systems and ProcessesThursday, April 28, 2022 at 11am PDT | 2pm EDT Are you ready for the challenges of going public? Whether you are a fast-growing biotech company or are currently public and looking for SOX compliance, this webinar will cover how to set up scalable and compliant financial processes.
Latest:
The Future of Obesity Pharmacology: Bridging Evidence Gaps with a New Model for Clinical RegistriesThe challenges in obesity research are significant, but the opportunities for innovation are equally profound.
Latest:
Reimagine Thought Leader Identification: Finding Enrollers and EducatorsKey opinion leaders may not be hard to find, but they are very hard to engage because everybody wants a piece of them.
Latest:
Changing the Paradigm in AI ImplementationHow pharma companies can reduce the risk of failure with AI-based innovations.
Latest:
The Price of Prescriptions: Getting it RightDrug companies face new hurdles in a rapidly changing marketplace. How do they finance new drug development amid the uncertainty?
Latest:
Patient Treatment & Travel: The Need for Stepped-Up SupportDesigning an effective travel and lodging patient hub program in pharma.
Latest:
Equity for Women in Healthcare: 131 Years is Too Long to WaitClosing the gender gap in pharma—and how we get there together.
Latest:
Passage to Asia: Early Access for Innovative TherapiesPharma looks to take advantage of expanded access programs across Asia-Pacific region.
Latest:
Industry Predictions For 2023Top industry experts weigh in on what the new year holds for the pharma industry.
Latest:
How Bringing Pharmacovigilance In-House Drives Better Oversight and Faster Data AnalysisFor companies in the life science industry, managing their processes in house on their own platforms proved beneficial.
Latest:
Technology Overload: Addressing Site Challenges of Digital TrialsWebinar Date/Time: Wednesday, August 30, 2023 at 11am EDT
Latest:
3 Reasons US Payers Will Make 2021 a Banner Year for BiosimilarsFollowing a year which saw a 143% increase in launched biosimilars in the US, here are three reasons why payers will drive adoption further in 2021.
